17.05.12 08:40 Uhr
REC Announces new Silicon Technologies Applications and Research Center in Shangyu, China - \"The solar polysilicon market has been very challenging this past nine months, especially in China. However, REC\'s NextSi(TM) granular polysilicon and FBR...
REC Announces new Silicon Technologies Applications and Research Center in Shangyu, China - \"The solar polysilicon market has been very challenging this past nine months, especially in China. However, REC\'s NextSi(TM) granular polysilicon and FBR...
17.05.12 08:05 Uhr
Patient Safety Group Renews Call for Urgent Action to Protect Patients From Harm - London (ots/PRNewswire) - The European Alliance for Access to Safe Medicines (EAASM) is calling for authorities to act now to clarify the conditions under...
Patient Safety Group Renews Call for Urgent Action to Protect Patients From Harm - London (ots/PRNewswire) - The European Alliance for Access to Safe Medicines (EAASM) is calling for authorities to act now to clarify the conditions under...
17.05.12 08:01 Uhr
SAMUEL DYER CORIAT, EXECUTIVE CHAIRMAN OF THE BOARD OF CAMPOSOL HOLDING PLC, APPOINTS PAVLOS ARISTODEMOU AS CHAIR OF THE ANNUAL GENERAL MEETING 2012 - Samuel Dyer Coriat, Executive Chairman of Camposol Holding Plc has appointed Pavlos Aristodemou, Director of Camposol Holding Plc as the person to chair the...
SAMUEL DYER CORIAT, EXECUTIVE CHAIRMAN OF THE BOARD OF CAMPOSOL HOLDING PLC, APPOINTS PAVLOS ARISTODEMOU AS CHAIR OF THE ANNUAL GENERAL MEETING 2012 - Samuel Dyer Coriat, Executive Chairman of Camposol Holding Plc has appointed Pavlos Aristodemou, Director of Camposol Holding Plc as the person to chair the...
17.05.12 07:31 Uhr
MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting - Synergistic Effects Seen with Four Approved Treatment Options Including Rituximab and...
MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting - Synergistic Effects Seen with Four Approved Treatment Options Including Rituximab and...
17.05.12 07:17 Uhr
Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients - * GLOW2 study showed NVA237 superior to placebo and similar to open-label tiotropium in increasing lung function, improving COPD symptoms and reducing...
Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients - * GLOW2 study showed NVA237 superior to placebo and similar to open-label tiotropium in increasing lung function, improving COPD symptoms and reducing...
17.05.12 00:02 Uhr
Van Andel Research Institute and Dako sign agreement to license cancer diagnostic tool - Grand Rapids, Mich. and Glostrup, Denmark (May 16, 2012) - Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer...
Van Andel Research Institute and Dako sign agreement to license cancer diagnostic tool - Grand Rapids, Mich. and Glostrup, Denmark (May 16, 2012) - Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer...
16.05.12 22:04 Uhr
Applied Materials to Present at Upcoming Investor Conference - A live webcast of the remarks will be available on Applied Materials\' website at: http://www.appliedmaterials.com/investor-relations. A replay of the webcast...
Applied Materials to Present at Upcoming Investor Conference - A live webcast of the remarks will be available on Applied Materials\' website at: http://www.appliedmaterials.com/investor-relations. A replay of the webcast...
16.05.12 21:04 Uhr
ASM International N.V. announces confirmation to carry out study into market valuation of the Company - The Company reiterates that it will carry out the study into the non-recognition by the markets of the value of the combined businesses of the Company in the...
ASM International N.V. announces confirmation to carry out study into market valuation of the Company - The Company reiterates that it will carry out the study into the non-recognition by the markets of the value of the combined businesses of the Company in the...
16.05.12 20:00 Uhr
Full Breadth and Depth of Accuray\'s Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31 - Sunnyvale, California (ots/PRNewswire) - Conference Presentations Highlighted Benefits of the CyberKnife(R) System\'s Motion Management and the TomoTherapy(R)...
Full Breadth and Depth of Accuray\'s Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31 - Sunnyvale, California (ots/PRNewswire) - Conference Presentations Highlighted Benefits of the CyberKnife(R) System\'s Motion Management and the TomoTherapy(R)...
16.05.12 19:42 Uhr
Svein Aaser valgt til ny styreleder i Telenor ASA - Svein Aaser var konsernsjef i Den norske Bank og DnB NOR fra 1998 til 2007. Han var tidligere konsernsjef i Nycomed fra 1987 til 1996. Aaser har også vært...
Svein Aaser valgt til ny styreleder i Telenor ASA - Svein Aaser var konsernsjef i Den norske Bank og DnB NOR fra 1998 til 2007. Han var tidligere konsernsjef i Nycomed fra 1987 til 1996. Aaser har også vært...
16.05.12 19:42 Uhr
Svein Aaser elected new Chairman of the Board of Telenor ASA - Svein Aaser was CEO of Den norske Bank and DnB NOR from 1998 to 2007. He was previously CEO of Nycomed from 1987 to 1996. He has also been the CEO of...
Svein Aaser elected new Chairman of the Board of Telenor ASA - Svein Aaser was CEO of Den norske Bank and DnB NOR from 1998 to 2007. He was previously CEO of Nycomed from 1987 to 1996. He has also been the CEO of...
gekennzeichnete Kurse stehen in realtime zur Verfügung.
gekennzeichnete Kurse der deutschen Börsen sind 15 Minuten verzögert, Kurse der internationalen Börsen sind 15 bzw. 20 Minuten verzögert.
dargestellt.